ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

Columbia Receives $1 Million ACS Grants

May 3, 1985

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

In Brief: Schilsky Named ASCO Chief Medical Officer

November 1, 2012

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

The Lancet Corrects Henschke Letters.

July 18, 2008